IP Library Granted Patent US 12,006,531
Granted Patent B2
US 12,006,531 · App. 16/674,876 · Granted Jun 11, 2024

Methods and systems for rapid detection of microorganisms using infectious agents

Inventors: Dwight Lyman Anderson (Minneapolis, MN); Jose S. Gil (Winnetka, CA); Ben Barrett Hopkins (Sherman Oaks, CA); Stephen Erickson (White Bear Township, MN)
Assignee: Laboratory Corporation of America Holdings
C12Q1/66C12N15/86G01N33/569G01N33/56911G01N33/581C12N2795/10121C12N2795/10131C12N2795/10143C12N2795/10221C12N2795/10231C12N2795/10243
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,006,531
App. No.
16/674,876
Granted
Jun 11, 2024
Kind
B2
Abstract

Disclosed herein are methods and systems for rapid detection of microorganisms in a sample, without culturing for enrichment of the microorganism. A modified bacteriophage is also disclosed which comprises a non-native indicator gene in the late gene region. The indicator product is not a fusion protein. The specificity of infectious agents allows a specific microorganism to be targeted, and an indicator signal may be amplified to optimize assay sensitivity.

Claims (14)

1. A method for detecting a bacterium of interest in a sample, the method comprising the steps of:

incubating at least one bacterium with a plurality of a bacteriophage genetically engineered to have an indicator gene inserted into a late gene region of the bacteriophage, wherein the indicator gene encodes a luciferase protein such that the luciferase protein is expressed during the replication of the bacteriophage and the luciferase protein does not form a fusion protein with a native gene product, and wherein the incubating step is performed at a temperature that is at least 37 degrees Celsius and no greater than 45 degrees Celsius; and

detecting the luciferase protein,

wherein detection of the luciferase protein indicates that the bacterium is present in the sample.

2. The method of claim 1 , wherein expression of the luciferase protein is driven by a viral capsid promoter and the luciferase is not incorporated into the structure of the bacteriophage.

3. The method of claim 1 , wherein the method is performed without culturing for enrichment of bacteria in the sample.

4. The method of claim 1 , wherein the bacteriophage express a luciferase protein.

5. The method of claim 1 , wherein the bacteriophage is T4 phage.

6. The method of claim 1 , wherein the bacterium is E. coli.

7. The method of claim 1 , wherein transcription of the indicator gene is driven by a constitutive bacterial promoter.

8. The method of claim 1 , wherein the method further comprises isolating the bacterium from other components in the sample before contacting with the plurality of the bacteriophage.

9. The method of claim 8 , wherein the isolating the bacterium comprises binding of the bacterium to a binding agent; or wherein the step of isolating the bacterium comprises contacting the bacterium with a binding agent that is bound to a solid support.

10. The method of claim 9 , wherein the binding agent is an antibody specific for the bacterium.

11. The method of claim 8 , wherein isolating comprises concentrating the bacterium from the sample on a bacteriological filter.

Continuity (5)
Continuation 14625481 · Feb 18, 2015
Continuation In Part 13773339 · Feb 21, 2013
Provisional Application 61940959 · Feb 18, 2014
Provisional Application 61601231 · Feb 21, 2012
Related Publication 20200140919A1 · May 7, 2020